Daniele Vecchio

Dr. Daniele Vecchio

Sapienza Univeristy of Rome
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2022 in Cells
Verified
Journal Article
Open access
PDF file
LSLeonardo Schirone
Leonardo Schirone
Maurizio ForteMaurizio Forte
Maurizio Forte
LDLuca D'ambrosio
Luca D'ambrosio
VVValentina Valenti
Valentina Valenti
DVDaniele Vecchio
Daniele Vecchio
SSSebastiano Sciarretta
Sebastiano Sciarretta
Cardiovascular disease is the leading cause of death in western countries. Among cardiovascular diseases, myocardial infarction represents a life-threatening condition predisposing to the development of heart failure. In recent decades, much effort has been invested in studying the molecular mechanisms underlying the development and progression of ischemia/reperfusion (I/R) injury and post-ischemic cardiac remodeling. These mechanisms include metabolic alterations, ROS overproduction, inflammation, autophagy deregulation and mitochondrial dysfunction. This review article discusses the most recent evidence regarding the molecular basis of myocardial ischemic injury and the new potential therapeutic interventions for boosting cardioprotection and attenuating cardiac remodeling.

1 November 2021 in Pharmacological Research
Verified
Journal Article
Closed access
Maurizio ForteMaurizio Forte
Maurizio Forte
SMSimona Marchitti
Simona Marchitti
MCMaria Cotugno
Maria Cotugno
FNFlavio Di Nonno
Flavio Di Nonno
RSRosita Stanzione
Rosita Stanzione
SSSebastiano Sciarretta
Sebastiano Sciarretta

29 January 2021 in British Journal of Pharmacology
Verified
Journal Article
Closed access
PDF file
Roberto CarnevaleRoberto Carnevale
Roberto Carnevale
CNCristina Nocella
Cristina Nocella
SSSonia Schiavon
Sonia Schiavon
VCVittoria Cammisotto
Vittoria Cammisotto
MCMaria Cotugno
Maria Cotugno
SSSebastiano Sciarretta
Sebastiano Sciarretta

15 December 2020 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
GFGiacomo Frati
Giacomo Frati
Maurizio ForteMaurizio Forte
Maurizio Forte
FNFlavio di Nonno
Flavio di Nonno
ABAntonella Bordin
Antonella Bordin
Isotta ChimentiIsotta Chimenti
Isotta Chimenti
SSSebastiano Sciarretta
Sebastiano Sciarretta
Background: The role of microRNAs dysregulation in tobacco cigarette smoking–induced vascular damage still needs to be clarified. We assessed the acute effects of tobacco cigarette smoking on endothelial cell‐related circulating microRNAs in healthy subjects. In addition, we investigated the potential role of microRNAs in smoking‐dependent endothelial cell damage. Methods and Results: A panel of endothelial‐related microRNAs was quantified in healthy subjects before and after smoking 1 tobacco cigarette. Serum levels of miR‐155 were found to be significantly increased shortly after smoking. We also observed a progressive and significant miR‐155 accumulation in culture media of human endothelial cells after 30 minutes and up to 4 hours of cigarette smoke condensate treatment in vitro without evidence of cell death, indicating that miR‐155 can be released by endothelial cells in response to smoking stress. Cigarette smoke condensate appeared to enhance oxidative stress and impair cell survival, angiogenesis, and NO metabolism in human endothelial cells. Notably, these effects were abrogated by miR‐155 inhibition. We also observed that miR‐155 inhibition rescued the deleterious effects of cigarette smoke condensate on endothelial‐mediated vascular relaxation and oxidative stress in isolated mouse mesenteric arteries. Finally, we found that exogenous miR‐155 overexpression mimics the effects of smoking stress by inducing the upregulation of inflammatory markers, impairing angiogenesis and reducing cell survival. These deleterious effects were associated with downregulation of vascular endothelial growth factor and endothelial NO synthetase. Conclusions: Our results suggest that miR‐155 dysregulation may contribute to the deleterious vascular effects of tobacco smoking.

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Mariarosaria BoccellinoMariarosaria Boccellino
Mariarosaria Boccellino
GGGiovanni Galasso
Giovanni Galasso
PAPASQUALINA AMBROSIO
PASQUALINA AMBROSIO
PSPaola Stiuso
Paola Stiuso
SLStefania Lama
Stefania Lama
MDMarina Di Domenico
Marina Di Domenico
The association between diabetes and cardiovascular diseases is well known. Related diabetes macro‐ and microangiopathies frequently induce hypoxia and consequently energy failure to satisfy the jeopardized myocardium basal needs. Additionally, it is widely accepted that diabetes impairs endothelial nitric oxide synthase (eNOS) activity, resulting in diminished nitric oxide (NO) bioavailability and consequent endothelial cell dysfunction. In this study, we analyzed the embryonic heart‐derived H9c2 cell response to hypoxic stress after administration of a high glucose concentration to reproduce a condition often observed in diabetes. We observed that 24 h hypoxia exposure of H9c2 cells reduced cell viability compared to cells grown in normoxic conditions. Cytotoxicity and early apoptosis were increased after exposure to high glucose administration. In addition, hypoxia induced a RhoA upregulation and a Bcl‐2 downregulation and lowered the ERK activation observed in normoxia at both glucose concentrations. Furthermore, a significant cell proliferation rate increases after the 1400 W iNOS inhibitor administration was observed. Again, hypoxia increased the expression level of myogenin, a marker of skeletal muscle cell differentiation. The cardiomyocyte gene expression profiles and morphology changes observed in response to pathological stimuli, as hypoxia, could lead to improper ventricular remodeling responsible for heart failure. Therefore, understanding cell signaling events that regulate cardiac response to hypoxia could be useful for the discovery of novel therapeutic approaches able to prevent heart diseases.

17 July 2021 in Life
Verified
Journal Article
Open access
PDF file
JMJacopo Morroni
Jacopo Morroni
LSLeonardo Schirone
Leonardo Schirone
DVDaniele Vecchio
Daniele Vecchio
CNCarmine Nicoletti
Carmine Nicoletti
LDLuca D'ambrosio
Luca D'ambrosio
Marina BoucheMarina Bouche
Marina Bouche
Chronic cardiac muscle inflammation and fibrosis are key features of Duchenne Muscular Dystrophy (DMD). Around 90% of 18-year-old patients already show signs of DMD-related cardiomyopathy, and cardiac failure is rising as the main cause of death among DMD patients. The evaluation of novel therapies for the treatment of dystrophic heart problems depends on the availability of animal models that closely mirror the human pathology. The widely used DMD animal model, the mdx mouse, presents a milder cardiac pathology compared to humans, with a late onset, which precludes large-scale and reliable studies. In this study, we used an exercise protocol to accelerate and worsen the cardiac pathology in mdx mice. The mice were subjected to a 1 h-long running session on a treadmill, at moderate speed, twice a week for 8 weeks. We demonstrate that subjecting young mdx mice (4-week-old) to “endurance” exercise accelerates heart pathology progression, as shown by early fibrosis deposition, increases necrosis and inflammation, and reduces heart function compared to controls. We believe that our exercised mdx model represents an easily reproducible and useful tool to study the molecular and cellular networks involved in dystrophic heart alterations, as well as to evaluate novel therapeutic strategies aimed at ameliorating dystrophic heart pathology.